Mankind Pharma Limited (MANKIND.NS)
INR 2350.5
(1.58%)
INR 2350.5
(1.58%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 29.27 Billion INR | 181.76% |
| 2022 | 17.7 Billion INR | -48.44% |
| 2021 | 34.33 Billion INR | 23.37% |
| 2020 | 27.82 Billion INR | 12.53% |
| 2019 | 24.73 Billion INR | 6.63% |
| 2018 | 23.19 Billion INR | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q1 | 7.65 Billion INR | -37.13% |
| 2023 Q1 | 11.91 Billion INR | 155.39% |
| 2023 Q2 | 12.97 Billion INR | 8.89% |
| 2023 Q3 | 12.82 Billion INR | -1.12% |
| 2023 Q4 | 12.17 Billion INR | -5.08% |
| 2023 FY | 49.88 Billion INR | 181.76% |
| 2022 Q1 | 10.46 Billion INR | 14.49% |
| 2022 FY | 17.7 Billion INR | -48.44% |
| 2022 Q4 | 4.66 Billion INR | -52.7% |
| 2022 Q2 | 10.76 Billion INR | 2.84% |
| 2022 Q3 | 9.86 Billion INR | -8.37% |
| 2021 FY | 34.33 Billion INR | 23.37% |
| 2021 Q4 | 9.14 Billion INR | 0.0% |
| 2020 FY | 27.82 Billion INR | 12.53% |
| 2019 FY | 24.73 Billion INR | 6.63% |
| 2018 FY | 23.19 Billion INR | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| Alembic Pharmaceuticals Limited | 15.86 Billion INR | -84.458% |
| Hester Biosciences Limited | 908.84 Million INR | -3120.907% |
| Aarti Drugs Limited | 1.16 Billion INR | -2407.359% |
| Aarti Pharmalabs Limited | 3.07 Billion INR | -852.15% |
| Albert David Limited | 1.02 Billion INR | -2752.7% |
| Alembic Limited | 872.45 Million INR | -3255.221% |
| Alkem Laboratories Limited | 32.83 Billion INR | 10.849% |
| Bafna Pharmaceuticals Limited | 455.58 Million INR | -6325.342% |
| Bajaj HealthCare Limited | 985.34 Million INR | -2870.827% |
| Biofil Chemicals and Pharmaceuticals Limited | 6.82 Million INR | -429121.32% |
| Brooks Laboratories Limited | 51.18 Million INR | -57095.963% |
| Eris Lifesciences Limited | 4.94 Billion INR | -492.216% |
| FDC Limited | 3.49 Billion INR | -736.426% |
| Glenmark Life Sciences Limited | 11.64 Billion INR | -151.47% |
| Gufic Biosciences Limited | 1.18 Billion INR | -2366.978% |
| Hikal Limited | 4.46 Billion INR | -555.784% |
| Ind-Swift Limited | 946.56 Million INR | -2992.533% |
| Innova Captab Limited | 931.03 Million INR | -3044.141% |
| IOL Chemicals and Pharmaceuticals Limited | 2.2 Billion INR | -1229.982% |
| Jagsonpal Pharmaceuticals Limited | 438.55 Million INR | -6574.927% |
| Jubilant Pharmova Limited | 14.45 Billion INR | -102.525% |
| Lincoln Pharmaceuticals Limited | 1.07 Billion INR | -2625.123% |
| Lupin Limited | 125.09 Billion INR | 76.6% |
| Mangalam Drugs & Organics Limited | 162.22 Million INR | -17944.292% |
| Medico Remedies Limited | 59.67 Million INR | -48953.865% |
| Morepen Laboratories Limited | 1.98 Billion INR | -1372.887% |
| Nectar Lifesciences Limited | 932.7 Million INR | -3038.511% |
| Orchid Pharma Limited | 800.77 Million INR | -3555.589% |
| Procter & Gamble Health Limited | 2.99 Billion INR | -877.262% |
| RPG Life Sciences Limited | 1.63 Billion INR | -1689.844% |
| Kilitch Drugs (India) Limited | 412.42 Million INR | -6997.715% |
| Sigachi Industries Limited | 579.88 Million INR | -4948.034% |
| Solara Active Pharma Sciences Limited | 2.55 Billion INR | -1046.114% |
| Suven Pharmaceuticals Limited | 1.4 Billion INR | -1986.764% |
| Themis Medicare Limited | 1.12 Billion INR | -2500.191% |
| Unichem Laboratories Limited | 6.72 Billion INR | -335.228% |
| Vaishali Pharma Limited | 84.02 Million INR | -34736.656% |
| Wanbury Limited | 978.96 Million INR | -2890.185% |
| Windlas Biotech Limited | 1 Billion INR | -2808.356% |
| ZIM Laboratories Limited | 1.01 Billion INR | -2789.558% |
| Ind-Swift Laboratories Limited | 2.12 Billion INR | -1278.077% |
| Ipca Laboratories Limited | 18.98 Billion INR | -54.168% |
| Sun Pharmaceutical Industries Limited | 154.18 Billion INR | 81.014% |
| Venus Remedies Limited | 1.91 Billion INR | -1427.586% |
| Sakar Healthcare Limited | 204.07 Million INR | -14243.903% |
| Aurobindo Pharma Limited | 55.65 Billion INR | 47.406% |
| Divi's Laboratories Limited | 14.17 Billion INR | -106.584% |
| AstraZeneca Pharma India Limited | 2.47 Billion INR | -1083.46% |
| Sequent Scientific Limited | 2.9 Billion INR | -908.781% |
| Laurus Labs Limited | 11.9 Billion INR | -145.788% |
| Neuland Laboratories Limited | 2.92 Billion INR | -899.161% |
| J. B. Chemicals & Pharmaceuticals Limited | 14.79 Billion INR | -97.89% |
| Glenmark Pharmaceuticals Limited | 46.95 Billion INR | 37.654% |
| Zydus Lifesciences Limited | 125.21 Billion INR | 76.621% |
| Amrutanjan Health Care Limited | 2.09 Billion INR | -1297.917% |
| Wockhardt Limited | 8.48 Billion INR | -245.199% |
| Bal Pharma Limited | 555.62 Million INR | -5168.453% |
| Dr. Reddy's Laboratories Limited | 95.87 Billion INR | 69.469% |
| Bliss GVS Pharma Limited | 1.41 Billion INR | -1962.601% |
| Par Drugs and Chemicals Limited | 58.28 Million INR | -50121.117% |
| Caplin Point Laboratories Limited | 2.17 Billion INR | -1246.19% |
| Shilpa Medicare Limited | 3.33 Billion INR | -777.965% |
| Valiant Laboratories Limited | 138.02 Million INR | -21107.785% |
| Ajanta Pharma Limited | 30.46 Billion INR | 3.906% |
| Aarey Drugs & Pharmaceuticals Limited | 14.21 Million INR | -205858.587% |
| Granules India Limited | 10.31 Billion INR | -183.85% |
| Medicamen Biotech Limited | 335.16 Million INR | -8633.823% |
| Syncom Formulations (India) Limited | 345.63 Million INR | -8369.357% |
| Piramal Enterprises Limited | 63.65 Billion INR | 54.012% |
| Torrent Pharmaceuticals Limited | 21.42 Billion INR | -36.648% |
| NATCO Pharma Limited | 10.05 Billion INR | -191.041% |
| Suven Life Sciences Limited | 109.75 Million INR | -26572.341% |
| Krebs Biochemicals & Industries Limited | 46.15 Million INR | -63321.644% |
| Strides Pharma Science Limited | 9.16 Billion INR | -219.493% |
| Indoco Remedies Limited | 12.06 Billion INR | -142.703% |
| Alpa Laboratories Limited | 127.38 Million INR | -22880.762% |
| Lasa Supergenerics Limited | 291.17 Million INR | -9953.402% |
| Sun Pharma Advanced Research Company Limited | 3.07 Billion INR | -851.407% |